1
|
Vom Saal FS. Flaws in design, execution and interpretation limit CLARITY-BPA's value for risk assessments of bisphenol A. Basic Clin Pharmacol Toxicol 2019; 125 Suppl 3:32-43. [PMID: 30589220 DOI: 10.1111/bcpt.13195] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Accepted: 12/14/2018] [Indexed: 11/27/2022]
Abstract
The Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA) involved the Food and Drug Administration, the National Toxicology Program and 14 academic investigators funded by the National Institute of Environmental Health Sciences. Two key questions to be answered by CLARITY-BPA were as follows: (1) Would the academic investigator studies show effects at low doses of bisphenol A (BPA) while the core guideline study conducted by the FDA only showed toxic effects at high doses? (2) Would the academic investigators be able to replicate their numerous prior studies with animals raised and treated in the FDA's toxicology centre? Several flaws in the design and execution of CLARITY-BPA biased the experiment towards not finding significant results (Type 2 error): (1) use of the oestrogen-insensitive NCTR CD-SD rat, (2) use of a stressful daily gavage BPA administration procedure throughout life, (3) lack of inclusion of non-gavaged negative controls and (4) lack of a comprehensive examination of animals for BPA contamination. In spite of these flaws, in some of the experiments conducted by CLARITY-BPA academic investigators, and also in the FDA's core study, there were significant low-dose effects, but these were ignored by the FDA. Thus, immediately after releasing the results from their core portion of CLARITY-BPA, the FDA issued a statement concluding BPA was "safe," and they ignored non-monotonic dose-response relationships. The FDA should not base its BPA risk assessment only on outdated guideline studies, but instead on the vast (~8000) number of publications documenting the similar health hazards BPA poses to animals and humans.
Collapse
Affiliation(s)
- Frederick S Vom Saal
- Division of Biological Sciences, University of Missouri-Columbia, Columbia, Missouri
| |
Collapse
|
2
|
Chang LL, Wun WSA, Wang PS. An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells. BMC Pharmacol Toxicol 2018; 19:45. [PMID: 30021644 PMCID: PMC6052566 DOI: 10.1186/s40360-018-0235-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2017] [Accepted: 07/05/2018] [Indexed: 12/26/2022] Open
Abstract
Background Nonylphenol (NP) is an environmental endocrine-disrupting chemical (EDC) detected in human cord blood and milk. NP exposure in developmental periods results in hyperadrenalism and increasing 11β-hydroxysteroid dehydrogenase I (11β-HSD1) activity in an adult rat model. Alleviating 11β-HSD1 activity is therefore a logical and common way to treat hyperadrenalism. PF915275 (PF; 4′-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide) is a selective inhibitor for 11β-HSD1. This study aimed to determine whether PF915275 could alleviate the hyperadrenalism induced by NP. In addition to a rat model, the effects of NP and PF915275 were measured in human preadipocytes. Methods For the in vivo rat model, female adult rats exposed to NP during the developmental period were divided into two treatment groups, with one receiving oral DMSO solution and the other receiving PF915275 once per day for 4 weeks. After the final treatment, the rats from each group were sacrificed for analysis. For the in vitro human model, human preadipocytes received 2 regimens of NP treatment. One treatment regimen occurred before differentiation (to mimic the sensitive developmental period; P exposure), and the other included continuous exposure from preadipocytes to fully differentiated adipocytes (to mimic the growing and adult periods, respectively; C exposure). Protein and RNA were extracted from rat tissues and the preadipocytes for western blot and real-time PCR analysis. Results In the rat model, PF915275 alleviated NP-induced effects by interfering with adipogenesis pathways, including enhancing PPARα expression, decreasing PPARγ expression, and reducing both 11β-HSD1 protein and mRNA expression levels. Additionally, PF915275 reduced the effects of the adrenal corticoid synthesis pathway by reducing StAR expression and 11β-hydroxylase and aldosterone synthase activities. With short-term exposure, NP enhanced PPARγ and FASN mRNA expression levels and reduced PPARα expression, whereas PF915275 alleviated these effects. With C exposure, the NP-induced accumulation of intracellular lipids was reduced by PF915275 treatment, which was mediated by decreased PPARγ mRNA and protein expression levels and increased PPARα protein expression. Conclusions The effects of NP and PF915275 treatment in both rat and human cell models are similar. Rats may be an appropriate model to study the effects of NP in humans, especially during the developmental period.
Collapse
Affiliation(s)
- Ling-Ling Chang
- Department of Chemical and Materials Engineering, Chinese Culture University, Shih-Lin, Taipei, 11114, Taiwan, Republic of China.
| | | | - Paulus S Wang
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan, Republic of China.,Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, 11217, Taiwan, Republic of China.,Medical Center of Aging Research, China Medical University Hospital, Taichung, 40402, Taiwan, Republic of China.,Department of Biotechnology, Asia University, Taichung, 41354, Taiwan, Republic of China
| |
Collapse
|
3
|
Chang LL, Wun WSA, Wang PS. Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-β hydroxysteroid dehydrogenase type 1. Environ Toxicol Pharmacol 2016; 44:1-12. [PMID: 27060500 DOI: 10.1016/j.etap.2016.03.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2015] [Revised: 03/23/2016] [Accepted: 03/25/2016] [Indexed: 06/05/2023]
Abstract
We previously observed that nonylphenol (NP) exposure during development resulted in increases in body weight and hyperadrenalism in adult male offspring. The mechanism of hyperadrenalism includes the primary activation of the adrenal gland and the conversion of inactive glucocorticoids to active glucocorticoids by 11β-HSD1. The inhibition of 11β-HSD1 is investigated as a new therapeutic approach. This study examined the effect of PF915275 (a selective 11β-HSD1 inhibitor) on hyperadrenalism and adipogenesis in male rats exposed to NP during development. The results showed that treatment with the 11β-HSD1 inhibitor PF915275 reversed/alleviated NP-induced hyperadrenalism via the following mechanisms: (1) decreasing serum corticosterone, 11β-hydroxylase, and aldosterone synthase levels; (2) significantly increasing PPARα protein and mRNA expression. In adipose tissue, NP significantly increased PPARγ mRNA expression, whereas PF915275 significantly decreased the level of mRNA expression; and (3) the expression of key regulators/enzymes in the adipogenesis metabolic pathway was also modulated.
Collapse
Affiliation(s)
- Ling-Ling Chang
- Department of Chemical and Materials Engineering, Chinese Culture University, Taipei 11114, Taiwan, ROC.
| | | | - Paulus S Wang
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan, ROC; Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan, ROC; Medical Center of Aging Research, China Medical University Hospital, Taichung 40402, Taiwan, ROC; Department of Biotechnology, Asia University, Taichung 41354, Taiwan, ROC.
| |
Collapse
|
4
|
Mecawi AS, Macchione AF, Nuñez P, Perillan C, Reis LC, Vivas L, Arguelles J. Developmental programing of thirst and sodium appetite. Neurosci Biobehav Rev 2015; 51:1-14. [DOI: 10.1016/j.neubiorev.2014.12.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2014] [Revised: 12/05/2014] [Accepted: 12/09/2014] [Indexed: 01/17/2023]
|
5
|
Chang LL, Wun WSA, Wang PS. Recovery from developmental nonylphenol exposure is possible for female rats. Chem Biol Interact 2014; 221:52-60. [DOI: 10.1016/j.cbi.2014.07.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2014] [Revised: 07/04/2014] [Accepted: 07/25/2014] [Indexed: 11/25/2022]
|
6
|
Boudalia S, Berges R, Chabanet C, Folia M, Decocq L, Pasquis B, Abdennebi-Najar L, Canivenc-Lavier MC. A multi-generational study on low-dose BPA exposure in Wistar rats: effects on maternal behavior, flavor intake and development. Neurotoxicol Teratol 2013; 41:16-26. [PMID: 24269606 DOI: 10.1016/j.ntt.2013.11.002] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Revised: 11/01/2013] [Accepted: 11/07/2013] [Indexed: 11/16/2022]
Abstract
Bisphenol A (BPA) is a common endocrine disruptor found as an environmental and food contaminant. It exerts both developmental and behavioral effects, mainly when exposure occurs in early life. The aim of this study was to determine the multi-generational effects of chronic, human-relevant low-dose exposure to BPA on development, maternal behavior and flavor preference in Wistar rats. BPA was orally administered at a daily dose of 5 μg/kg body weight to F0 pregnant dams from the first day of gestation (GD 1) until the last day of lactation (LD 21), and then to F1 offspring from weaning (PND 21) to adulthood (PND 100). F2 offspring were not exposed. Development and clinical signs of toxicity were assessed daily. Maternal behavior was evaluated by observing nursing and pup-caring actions, as well as "non-maternal" behaviors in F0 and F1 dams from parturition until LD 8. The flavor preferences of F1 and F2 offspring were evaluated based on the intake of sweet, salt and fat solutions using the two-bottle choice test on PND 21-34 and PND 86-99. BPA exposure: 1) decreased maternal behavior in F1 dams, 2) caused developmental defects in both F1 and F2 offspring, with a noticeable decrease in anogenital distance in male rats, and 3) did not affect flavored solution intake in F1, but induced changes in sweet preference in F2 juveniles and in salt and fat solution intakes in F2 adults, and 4) induced a body weight increase in the F2 generation only, whereas food intake and water consumption did not change. Taken as a whole, our findings showed that both gestational (F0) and lifelong (F1) exposures to a human-relevant dose of BPA could induce multi-generational effects on both development and behavior. These results suggest possible selective neuroendocrine defects and/or epigenetic changes caused by BPA exposure.
Collapse
Affiliation(s)
- Sofiane Boudalia
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France
| | - Raymond Berges
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France
| | - Claire Chabanet
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France
| | - Mireille Folia
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Laurence Decocq
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France
| | - Bruno Pasquis
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France
| | | | - Marie-Chantal Canivenc-Lavier
- INRA, UMR1324, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; CNRS, UMR6265, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France; Université de Bourgogne, Centre des Sciences du Goût et de l'Alimentation, 21000 Dijon, France.
| |
Collapse
|
7
|
Abstract
BACKGROUND The concept of developmental programming suggests that the early life environment influences offspring characteristics in later life, including the propensity to develop diseases such as the metabolic syndrome. There is now growing evidence that the effects of developmental programming may also manifest in further generations without further suboptimal exposure. This review considers the evidence, primarily from rodent models, for effects persisting to subsequent generations, and evaluates the mechanisms by which developmental programming may be transmitted to further generations. In particular, we focus on the potential role of the intrauterine environment in contributing to a developmentally programmed phenotype in subsequent generations. METHODS The literature was systematically searched at http://pubmed.org and http://scholar.google.com to identify published findings regarding transgenerational (F2 and beyond) developmental programming effects in human populations and animal models. RESULTS Transmission of programming effects is often viewed as a form of epigenetic inheritance, either via the maternal or paternal line. Evidence exists for both germline and somatic inheritance of epigenetic modifications which may be responsible for phenotypic changes in further generations. However, there is increasing evidence for the role of both extra-genomic components of the zygote and the interaction of the developing conceptus with the intrauterine environment in propagating programming effects. CONCLUSIONS The contribution of a suboptimal reproductive tract environment or maternal adaptations to pregnancy may be critical to inheritance of programming effects via the maternal line. As the effects of age exacerbate the programmed metabolic phenotype, advancing maternal age may increase the likelihood of developmental programming effects being transmitted to further generations. We suggest that developmental programming effects could be propagated through the maternal line de novo in generations beyond F2 as a consequence of development in a suboptimally developed intrauterine tract and not necessarily though directly transmitted epigenetic mechanisms.
Collapse
Affiliation(s)
- Catherine E Aiken
- University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK
| | | |
Collapse
|
8
|
Abstract
This review focuses on how maternal prenatal nutritional states may affect the health of grandchildren and later generations. We first summarize the limited current data in human populations relating to the potential transmission of phenotypes across multiple generations that result from the nutritional experience of a pregnant woman. We then discuss findings from other species, especially mammals, that provide important clues as to whether, and if so how, such transmission could occur in humans. Finally, we consider how studies of human populations could be best designed to detect transmission across multiple generations. We argue that just as epidemiologists embraced a life-course perspective to human health and disease in the twentieth century, we must now seek to better understand how health and disease could be shaped across multiple generations.
Collapse
Affiliation(s)
- E. Susser
- Imprints Center for Genetic and Environmental Life Course Studies, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032
| | - J.B. Kirkbride
- Imprints Center for Genetic and Environmental Life Course Studies, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032
- EpiCentre, Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom
| | - B.T. Heijmans
- Molecular Epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - J.K. Kresovich
- Imprints Center for Genetic and Environmental Life Course Studies, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032
| | - L.H. Lumey
- Imprints Center for Genetic and Environmental Life Course Studies, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032
| | - A.D. Stein
- Rollins School of Public Health, Emory University, Atlanta, Georgia 30322
| |
Collapse
|
9
|
Chang LL, Wun WSA, Wang PS. In utero and neonate exposure to nonylphenol develops hyperadrenalism and metabolic syndrome later in life. I. First generation rats (F(1)). Toxicology 2012; 301:40-9. [PMID: 22765982 DOI: 10.1016/j.tox.2012.06.017] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2012] [Revised: 06/17/2012] [Accepted: 06/23/2012] [Indexed: 10/28/2022]
Abstract
Nonylphenol (NP) is an endocrine disruptor (ENDR). It is a chemical associated with the production and degradation of nonylphenol ethoxylates (NPE). NPE is widely used as nonionic surfactants. Previously, we observed that NP increased the production of corticosterone and aldosterone from zona fasciculata-reticularis, and zona glomerulosa cells, respectively. By the "fetal origins adult diseases" (Barker hypothesis), we examined the possible impact of NP exposure during developmental (in utero and neonatal) period with focus on disturbed adrenal function and related hyperadrenal syndrome, i.e. Cushings syndrome/metabolic syndrome. In this study, female rats drink NP water during pregnancy and lactation conferred F(1) generation: (1) increase the corticosterone, aldosterone concentration in plasma; (2) increase 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity in liver and adipose tissue; (3) increase aldosterone synthase activity in adrenal for adult offspring. Furthermore, it can increase body weight, adrenocorticotropin (ACTH) concentration in plasma, 11β-HSD1 protein expression in liver, steroidogenic acute regulatory (StAR) protein expression and 11β-hydroxylase activity in adrenal for male adult offspring. In summary, NP exposure during developmental period bestowed F(1) generation with hyperadrenalism and its consequence of metabolic syndrome.
Collapse
Affiliation(s)
- Ling-Ling Chang
- Department of Chemical and Materials Engineering, Chinese Culture University, Taipei 11114, Taiwan, ROC.
| | | | | |
Collapse
|
10
|
Brown NM, Lindley SL, Witte DP, Setchell KD. Impact of perinatal exposure to equol enantiomers on reproductive development in rodents. Reprod Toxicol 2011; 32:33-42. [PMID: 21620954 DOI: 10.1016/j.reprotox.2011.05.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2011] [Revised: 04/15/2011] [Accepted: 05/12/2011] [Indexed: 11/22/2022]
Abstract
There is now considerable interest in the intestinally derived soy isoflavone metabolite, equol, which occurs in the enantiomeric forms, S-(-)equol and R-(+)equol, both differing in biological actions. Little is known about effects of either enantiomer on reproductive development, yet such knowledge is fundamental because of the recent commercialization of S-(-)equol as a dietary supplement. S-(-)equol and R-(+)equol were therefore investigated to determine their effects on reproductive development and fertility in the Sprague-Dawley rat. Neither enantiomer affected fertility, number of litters produced, number of pups per litter, number of male and female pups born, birth weight, anogenital distance, testicular descent or vaginal opening. Histological analysis showed no major abnormalities in ovary, testis, prostate or seminal vesicle tissue with dietary exposure to S-(-)equol or R-(+)equol, but both enantiomers triggered hyperplasia of uterine tissue. With R-(+)equol this stimulatory effect subsided after exposure was discontinued, but the effect of S-(-)equol was prolonged.
Collapse
|
11
|
Ujházy E, Mach M, Navarová J, Brucknerová I, Dubovický M. Safety assessment of the pyridoindole derivative SMe1EC2: developmental neurotoxicity study in rats. Interdiscip Toxicol 2011; 4:47-51. [PMID: 21577284 PMCID: PMC3090054 DOI: 10.2478/v10102-011-0009-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2011] [Revised: 03/13/2011] [Accepted: 03/17/2011] [Indexed: 11/29/2022] Open
Abstract
The present study deals with effect of prenatal and neonatal administration of the synthetic pyridoindole derivative SMe1EC2 (2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3b] indolinium chloride) on postnatal and neurobehavioral development of the rat offspring. The substance tested was administered to pregnant rats orally in the doses 5, 50 and 250 mg/kg from day 15 of gestation to day 10 post partum (PP). From the day 4 PP, the postnatal development and neurobehavioral characteritics of offspring were evaluated. The following variables were observed: body weight, pinna detachment, incisor eruption, ear opening, eye opening, testes descent and vaginal opening, righting reflex, negative geotaxia, startle reflex, dynamic air righting and exploratory behavior in a new environment. No maternal death, abortion or dead fetuses occurred either in the control or SMe1EC2 groups. Dynamic righting reflex was delayed one day in the groups of animals treated via their mothers with 5 and 50 mg/kg SMe1EC2. The delay in the development of this reflex was only transient. On day 20 PP, all pups tested had a positive score of the reflex. Administration of SMe1EC2 did not reveal any significant changes in other variables of somatic growth and maturation, reflex and neuromotor development and exploratory behavior, either of young or adult animals of both genders, assessed by analysis of variance.
Collapse
Affiliation(s)
- Eduard Ujházy
- Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
| | - Mojmír Mach
- Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
| | - Jana Navarová
- Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
| | - Ingrid Brucknerová
- 1st Department of Pediatrics, Medical School, Comenius University, SK-83340 Bratislava, Slovak Republic
| | - Michal Dubovický
- Institute of Experimental Pharmacology & Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic
| |
Collapse
|